SecBot SecBot

UTHR

UNITED THERAPEUTICS Corp
Nasdaq· Pharmaceutical Preparations· Inc. DE· CIK 0001082554 Biotech & Drug Discovery
$587.88 −3.29 (−0.56%)
Nov 16 4:00 PM ET · prev $591.17
Market cap
$25.3B
Large cap
Consensus
Buy
82% Buy or better · 22 analysts
Median target
$711.50
+21% · range $390.00–850.00
1 year
+24.6%
from $471.92 · Nov 17
30 days
+8.2%
from $543.15
52-week range
$464.93–608.49
−3% from high · low Jan 16
Avg volume 20D
523.6K
shares / day
Short interest
1.84M
≈4.3% of shares · −25.2%
Days to cover
3.5
at average volume
Insider net
−$14.9M
since Nov 10 · excl. 12 subscriber-only trades
New fund stakes
6
Q2 2026 13F · 1 exit
Filing reports
123
analyzed by SecBot
SecBot read MIXED 44 reports · 90 days
Balance 4 bearish · 1 bullish · 2 mixed · 37 neutral oldest → newest, height = score
Avg score ·High conf. 32/44

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersMIXED

    1 insider sold $14.9M. Excludes 12 subscriber-only trades.

  • InstitutionsMIXED

    Q2 2026: 53 added (6 new), 38 trimmed or exited. Largest new: Arrowstreet Capital, Limited Partnership $45.4M, Worldquant Millennium Advisors $29.5M.

  • AnalystsBULLISH

    18 of 22 rate it Buy or better. Median target $711.50 (+21%).

  • Short sellersCOVERING

    Short interest −25.2% to 1.84M shares. 3.5 days to cover, ≈4.3% of shares.

  • TrendUPTREND

    8% above its 50-day average.

Who's buying

13F· Q2 2026
6
new positions
1
exit
$145.5M
in new stakes
FundMoveSharesValue
WELLINGTON MANAGEMENT GROUP LLPTRIM1,379,025$747.2M
MILLENNIUM MANAGEMENT LLCDOUBLED409,074$221.6M
JANE STREET GROUP, LLCDOUBLED285,926$154.9M
PRICE T ROWE ASSOCIATES INC /MD/TRIM243,444$131.9M
Qube Research & Technologies LtdADD233,639$126.6M
AmundiADD219,094$118.7M
Point72 Asset Management, L.P.ADD201,159$109.0M
TD ASSET MANAGEMENT INCADD168,649$91.4M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

22 analysts
Buy 82% rate it Buy or better
Strong Buy7Buy11Hold3Sell1Strong Sell0
12-month targets · 14 analysts

Price is inside the target range. Median implies +21%.Targets as of Nov 16, 2026.

Recent actions
DateFirmActionRating
Nov 5, 2026TD Cowen
MAINTAIN
MAINTAINBuy
Nov 5, 2026RBC Capital
MAINTAIN
MAINTAINOutperform
Nov 5, 2026Wells Fargo
MAINTAIN
MAINTAINOverweight
Nov 4, 2026BTIG
MAINTAIN
MAINTAINBuy
Oct 28, 2026JP Morgan
MAINTAIN
MAINTAINOverweight
Oct 22, 2026RBC Capital
MAINTAIN
MAINTAINOutperform

Insider ledger

Form 4
$0
bought · 0 insiders
$14.9M
sold · 1 insider · excl. 12 subscriber-only trades
DateInsiderTypeValue
Nov 13, 2026🔒 Fresh data, subscribers only
Nov 13, 2026
SELL
Nov 13, 2026🔒 Fresh data, subscribers only
Nov 13, 2026
SELL
Nov 13, 2026🔒 Fresh data, subscribers only
Nov 13, 2026
SELL
Nov 13, 2026🔒 Fresh data, subscribers only
Nov 13, 2026
SELL
Nov 13, 2026🔒 Fresh data, subscribers only
Nov 13, 2026
SELL
Nov 13, 2026🔒 Fresh data, subscribers only
Nov 13, 2026
SELL
Nov 13, 2026🔒 Fresh data, subscribers only
Nov 13, 2026
SELL
Nov 13, 2026🔒 Fresh data, subscribers only
Nov 13, 2026
SELL

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only

Washington

Corporate Lobbying

6 lobbying filings and 0 bills this company lobbies on, with spend, stage and how each bill touches it, are for subscribers.

Subscribe for Full Access

Short side

FINRA· Oct 30, 2026
1,837,654
shares short
-25.2%
vs prior settlement
3.5
days to cover
≈4.3%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 16, 2026 SEC
🔒 Fresh report (last 24h), subscribers only
Nov 13, 2026 SEC
CEO Martine Rothblatt executed a large option exercise and sold a portion of the resulting shares, totaling…
CLUSTER · Impact 4/10
Nov 13, 2026 Insider
🔒 Fresh data, subscribers only
Nov 13, 2026 Insider
🔒 Fresh data, subscribers only
Nov 13, 2026 Insider
🔒 Fresh data, subscribers only
Nov 12, 2026 SEC
Three insiders at United Therapeutics sold a total of $1.67M in open-market sales within a week of the company…
CLUSTER · Impact 2/10
Nov 4, 2026 Earnings result
UTHR Q3 2026 Earnings: EPS $5.71 (-12.9% vs est)
Jun 30, 2026 Inst.
WELLINGTON MANAGEMENT GROUP LLP · TRIM
1,379,025 shares ($747.2M)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent

SecBot reports

123 filings · 2 bullish · 8 bearish · 5 mixed · 108 neutral
All UTHR filing & press-release reports (123)